Esomeprazole/Meloxicam

埃索美拉唑/美洛昔康

Report date: 2024/04/11 14:26:08

Base Information

Drug NameEsomeprazole/Meloxicam
Drug Alias NameMeloxicam/Esomeprazole美洛昔康/埃索美拉唑Meloxicam+Esomeprazole埃索美拉唑+美洛昔康美洛昔康+埃索美拉唑 +[7
ClassificationSmall molecules
Mechanisms of ActionProton pump inhibitorsCyclooxygenase-2 inhibitorsCyclooxygenase-1 inhibitors
TargetsCyclooxygenase-2Proton pumpCyclooxygenase-1
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAxsome Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAxsome Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A